Jun Naniwa Selected Research

Jun Naniwa Research Topics

5	Neoplasms (Cancer) 08/2014 - 05/2004
4	Ovarian Neoplasms (Ovarian Cancer) 07/2012 - 03/2004
3	Carcinoma (Carcinomatosis) 08/2014 - 07/2012
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2014 - 12/2003
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 03/2014 - 03/2009
2	Ovarian Epithelial Carcinoma 07/2011 - 05/2004
2	Endometrial Neoplasms (Endometrial Cancer) 07/2009 - 03/2006
1	Weight Loss (Weight Reduction) 03/2014

3	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 12/2003
2	dactolisibIBA 08/2014 - 03/2014
2	Phosphatidylinositols (Phosphatidylinositol)IBA 03/2014 - 07/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2014 - 07/2011
2	PlatinumIBA 07/2012 - 05/2004
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2009 - 03/2004
2	Proteins (Proteins, Gene)FDA Link 03/2006 - 12/2003
1	TOR Serine-Threonine KinasesIBA 03/2014
1	3- (carbamoylamino)- 5- (3- fluorophenyl)- N- (3- piperidyl)thiophene- 2- carboxamideIBA 01/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	Drug CombinationsIBA 01/2014
1	Myristic Acid (Tetradecanoic Acid)IBA 07/2012
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 07/2012
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2012
1	Acetates (Acetic Acid Esters)FDA Link 07/2012
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 07/2012
1	phorbolIBA 07/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2012
1	Etoposide (VP 16)FDA LinkGeneric 07/2011
1	Sirolimus (Rapamycin)FDA Link 07/2011
1	Fluorouracil (Carac)FDA LinkGeneric 03/2009
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2009
1	Carboplatin (JM8)FDA LinkGeneric 03/2009
1	beta CateninIBA 03/2006
1	Docetaxel (Taxotere)FDA Link 03/2004
1	Oncogene Proteins (Oncogene Protein)IBA 12/2003

6	Drug Therapy (Chemotherapy) 08/2014 - 05/2004
2	Hysterectomy 04/2014 - 07/2009
1	Neoadjuvant Therapy 04/2014
1	Combination Drug Therapy (Combination Chemotherapy) 03/2009